Bayer investors shrug off major settlement with €17.5bn of demand for new bonds
Bayer, the German life sciences company, enjoyed blow-out demand for its €6bn multi-tranche bond issue on Wednesday, days after agreeing to pay up to $10.9bn to settle a lawsuit over claims its weedkiller, Roundup, causes cancer.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: